Weekly Refresh: Clearcover’s New Execs, Chicago VCs Are Optimistic, and More

August 31, 2020
chicago
Photo: Shutterstock

Abbott’s coronavirus test received FDA approval. Its rapid antigen test, called BinaxNOW, can potentially detect infection in just 15 minutes. It costs just $5 per test. [Built In Chicago]

Chicago VCs remain optimistic. Despite the COVID-19 pandemic, the tech leaders surveyed think the virus and response to it actually has the power to re-accelerate the startup community. [TechCrunch]

Azul 3D raised $12.5M. The company owns proprietary 3D printing technology and with the funds will launch its first commercial printers. This latest round brought its total funding raised to over $20 million. [Built In Chicago]

mHUB closed first round of $15M venture fund. mHUB Product Impact Fund I plans to invest in seed and early stage hardtech companies in the United States. Its goal is to raise a total of $15 million. Sam Zell is an investor in the fund. [Press Release]

Clearcover hired two new executives. The company offers car insurance powered by technology. It brought on Norman Smagley as chief financial officer and Vandana Venkat as chief insurance officer. [PRWeb]

Chicago startup guides

LOCAL GUIDE
Best Companies to Work for in Chicago
LOCAL GUIDE
Coolest Offices in Chicago Tech
LOCAL GUIDE
Best Perks at Chicago Tech Companies
LOCAL GUIDE
Women in Chicago Tech